12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD)

✍ Scribed by P. Papay; A. Eser; W. Miehsler; C. Lichtenberger; A. Mikulits; C. Dejaco; G. Novacek; H. Vogelsang; W. Reinisch

• Book ID: 119636118
• Publisher: Oxford University Press
• Year: 2009
• Tongue: English
• Weight: 54 KB
• Volume: 3
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/s1873-9946(09)60024-6